2011 National DNA Day Online Chatroom Transcript

This is just one question from an archive of the National DNA Day Moderated Chat held in April 2011. The NHGRI Director and many genomics experts from across NHGRI took questions from students, teachers and the general public on topics ranging from basic genomic research, to the genetic basis of disease, to ethical questions about genetic privacy.


342
Have you personally seen any impact on research/practices that was caused by the practice of gene patenting?
     Amy Gaviglio, M.S., C.G.C.: I am a genetic counselor at the MN Department of Health. I work in the newborn screening program and am involved in education surrounding public health genetics and ethics. I personally have had little exposure to gene patenting, except in the clinical realm with Myriad Genetics and their patents on the hereditary breast and ovarian cancer genes, BRCA1 and BRCA2. In this particular case, the impact is that all genetic testing for this must go through Myriad Genetics.
Boston University in MA (Higher Education student)


< View ALL questions and answers from 2011



(short, single keywords work best at first)